Haemodynamic effects of sacubitril/valsartan in advanced heart failure

Abstract Aims The angiotensin receptor–neprilysin inhibitor (ARNI), sacubitril/valsartan, has been shown to be effective in treatment of patients with heart failure (HF), but limited data are available in patients with advanced disease. This retrospective observational study assessed the effects of...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Piero Gentile, Rosaria Cantone, Enrico Perna, Enrico Ammirati, Marisa Varrenti, Luciana D'Angelo, Alessandro Verde, Grazia Foti, Gabriella Masciocco, Andrea Garascia, Maria Frigerio, Manlio Cipriani
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Oxford University Press 2022-04-01
Edice:	ESC Heart Failure
Témata:	Heart failure Sacubitril/valsartan Heart transplantation Pulmonary artery pressures Filling pressures Real‐life practice
On-line přístup:	https://doi.org/10.1002/ehf2.13755
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!